冠科美博2月24日股价下跌4.86% 成交额约12.97万美元

Stock Performance - On February 24, 2026, the stock price of APLM.OQ (冠科美博) fell by 4.86% (or 4.88% according to different data sources), closing at $20.08. The trading volume was 6,453 shares, with a total transaction value of $129,743, and the stock experienced a volatility of 12.46% [1] - The biotechnology sector in the US stock market saw a slight decline of 0.07% on the same day, while major indices like the Nasdaq rose by 1.04%, indicating that APLM.OQ underperformed compared to both its sector and the broader market [1] Company Situation - There were no significant fundamental announcements from the company on that day, such as financial reports, clinical progress, or business collaborations [2] - The stock's price fluctuation may be attributed to market sentiment, as recent analyses indicated a widespread sell-off in US tech stocks, with concerns about capital returns in high-investment areas like AI affecting growth sectors, including biotechnology [2] - The trading characteristics of APLM.OQ showed a volume ratio of 0.58, indicating lower trading activity compared to recent averages, which may have amplified price volatility. The company's price-to-earnings (TTM) and price-to-book ratios were -0.75 and -9.79, respectively, reflecting a long-term loss situation that could heighten investor caution [2]